Background: Iron deficiency anemia (IDA) is the most common problem of nutritional deficiency in pregnant women worldwide. There is a concern about the high prevalence of iron and other micronutrient deficiencies among women during pregnancy in developing countries, and maternal anemia continues to cause significant perinatal morbidity and mortality.
Objective: To compare between total dose of iron infusion and intramuscular iron administration from 12-32 weeks in pregnant women with moderate iron deficiency anemia.
Patients and Methods: The study was held on 100 patients in the Obstetrics and Gynecology Department at Al-Hussien University Hospital Al- Azhar University on pregnant women at 12-32 weeks gestation attending the antenatal care unit from September 2019 to March 2020.
Results: Group A was received I.V iron, Hb (pretherapy) ranged from 7.1-9 g%, elevated to 10.1-12 g%, the ferritin ranged from 15-30 ng/ml, elevated to 32-49 ng/ml. Group B was received I.M-iron, Hb (pretherapy) ranged from 7-9 g%, elevated to 8.5-10.9 g%, and ferritin ranged from 16-29ng/ml, elevated to 24-35ng/ml.
Conclusion: Intravenous iron showed high effectiveness in the treatment of iron deficiency anemia during pregnancy. No side effects were detected and thus, it can be considered as a useful and alternative formulation for the treatment of iron deficiency.